Zemedy Application for Irritable Bowel Syndrome

Stopped early · Not applicable

Conditions studied: IBS - Irritable Bowel Syndrome

In brief

The purpose of the study is investigate the effectiveness of Zemedy, a mobile application that enables the digital delivery of a CBT program to people with IBS.

Key facts

Study ID

NCT04723056

Run by

Stanford University

People needed

21

Starts

2021-10-15

Expected to finish

2024-03-08

Last updated by the study team

2025-05-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and female patients >=18 years old.
• Meet Rome IV criteria for IBS for at least 6 months. No restrictions on type of IBS.
• English proficiency (in order to understand use of the application.
• Patient must be on a stable regimen for IBS for at least 30 days.
• Patients must own a smartphone (iOS or Android) in order to participate in the CBT application.

You may not qualify if…

• Laboratory or imaging evidence of an alternative explanation of patient's symptoms.
• Active gastrointestinal disease such as Crohn's disease, ulcerative colitis, history of complete colon resection, acute infection, or any disease that precludes participation in CBT application.
• Patient already undergoing cognitive behavioral therapy.
• Psychiatric hospitalization within 10 years.
• Current or past diagnosis of a major mental illness such as schizophrenia, bipolar disorder, personality disorder or substance abuse.
• Active (within the past 3 months) suicidal ideation.
• Prisoners or other detained individuals.
• Adults unable to consent.
• Pregnant people.

Where it is running

• Stanford University School of Medicine — Redwood City, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.